Results 221 to 230 of about 55,546 (301)

Optimal volume for the draw-and-return methods to enhance activated partial thromboplastin time ratio accuracy in hemodialysis patients with central venous catheters. [PDF]

Heliyon
Thongdee C, Lumkul L, Wongyikul P, Spilles N, Laonapaporn B, Patumanond J, Phinyo P.   +6 more
europepmc   +1 more source

Delayed Postoperative Spinal Epidural Hematoma After Thoracic OPLL Surgery: A Case Report and Literature Review

Clinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT New axial pain with rapid neurological decline weeks after surgery for thoracic ossification of the posterior longitudinal ligament may signal delayed postoperative epidural hematoma. Immediate MRI and urgent decompression are critical. Consider occult clot‐stabilization defects such as factor XIII deficiency when routine coagulation tests are
Hayato Takei, Tetsuro Ohba, Nobuki Tanaka, Kotaro Oda, Kai Mizukami, Go Goto, Hirotaka Haro   +6 more
wiley   +1 more source

EFFECT OF METHANOLIC SEED EXTRACT OF PERSEA AMERICANA(AVOCADO PEAR) ON PROTHROMBIN TIME AND ACTIVATED PARTIAL THROMBOPLASTIN TIME IN MICE

, 2016

openalex   +1 more source

Unbelievable but true: Partial thromboplastin time, kaolin 120 s and yet no surgical bleed!

, 2017
ShagunBhatia Shah, Vani Bhageria, BinodKumar Naithani, AjayKumar Bhargava   +3 more
openalex   +1 more source

A Diagnostic Challenge: Post‐Transfusion Purpura Unmasked After Multiple Transfusions

Clinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT Post‐transfusion purpura (PTP) is a rare immune‐mediated post‐transfusion reaction resulting in severe thrombocytopenia. This case presents a 52‐year‐old female with profound thrombocytopenia following multiple transfusions. PTP was not initially suspected due to her history of comorbid anti‐phospholipid antibody syndrome (APS), chemotherapy ...
Jacintha Thomas, Priyal Gopalan, Tanya M. Wildes   +2 more
wiley   +1 more source

Prolongated Activated Partial Thromboplastin Time (aPTT) in Pediatric Patients before Surgery-Crying Wolf: Lupus (Anticoagulant) Does Not Always Threaten Children. [PDF]

J Clin Med
Martini T, Santoro RC, Banov L, Ierardi A, Leotta M, Strangio A, Svahn J, Molinari AC.   +7 more
europepmc   +1 more source

Figure 4 from: Zaid Sami A, Ali Farhan H, Mohammed Abbas H (2025) Targeting activated partial thromboplastin time of unfractionated heparin: the role of clinical pharmacist at the cardiac care unit. Pharmacia 72: 1-8. https://doi.org/10.3897/pharmacia.72.e163936

Zaid Sami, Aymen, Ali Farhan, Hasan, Mohammed Abbas, Hasan   +2 more
openalex   +1 more source

Multi‐Chamber Intracardiac Thrombi Complicated With Pulmonary and Lower Extremity Thrombosis in Male Patient: Case Report and Literature Reviews

Clinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT Multi‐chamber intracardiac thrombi are a rare and high‐risk complication in dilated cardiomyopathy, even during sinus rhythm. This case highlights the associated dangers of hemodynamic compromise and systemic embolization. Management requires vigilant anticoagulation and close monitoring to balance thromboembolic and bleeding risks.
Eba Fufa, Yitagesu Getachew, Samson Mulugeta, Abera Birhanu, Abel Yirga, Amdemeskel Mersha, Banchiaymolu Damtie, Balew Arega, Begashaw Belay, Brook Fanuel, Misgana Lukas   +10 more
wiley   +1 more source

Activated partial thromboplastin time (APTT), partial thromboplastin time (PTT)

Activated partial thromboplastin time (APTT), partial thromboplastin time (PTT)
openaire   +1 more source

Quantitative Model‐Informed Dose Selection for a Milvexian Phase III Study in Patients With Atrial Fibrillation

Clinical Pharmacology &Therapeutics, Volume 119, Issue 1, Page 139-146, January 2026.
Milvexian, an activated factor XI inhibitor, is being evaluated in the LIBREXIA phase III program for the prevention of thrombotic events, including in patients with atrial fibrillation (LIBREXIA AF). To guide the selection of a phase III dose regimen for LIBREXIA AF, two main approaches were used: (1) population pharmacokinetics and exposure–response ...
Wangda Zhou, Emily Bozenhardt, Gregory E. Alexander, Matthew L. Zierhut, Samira Merali, Antoinette Ajavon‐Hartmann, Peter Zannikos, Hyunmoon Back, EunYoung Suh, Navin Goyal, Mahesh N. Samtani, Alexei N. Plotnikov, Chandni Valiathan   +12 more
wiley   +1 more source